|[March 04, 2014]
Verastem to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass. --(Business Wire)--
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
announced that the Company will present at upcoming investor
conferences. The presentation details are as follows:
26th Annual Roth Conference on Monday, March 10th at
11:30 a.m. PT at The Ritz Carlton in Dana Point, CA (News - Alert)
Barclays Capital Global Healthcare Conference on Tuesday, March 11th
at 3:15 p.m. ET at the Loews Miami Hotel in Miami, FL
Webcasts of the presentations can be accessed by visiting the investors
section of the Company's website at ww.verastem.com.
Replays of each of the webcasts will be archived on the Verastem website
for 90 days following the presentation dates.
About Verastem, Inc.
Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to
treat cancer by the targeted killing of cancer
stem cells. Cancer stem cells are an underlying cause of tumor
recurrence and metastasis. Verastem is developing small molecule
inhibitors of signaling pathways that are critical to cancer stem cell
survival and proliferation: FAK, PI3K/mTOR and Wnt. For more
information, please visit www.verastem.com.
Any statements in this press release about future expectations, plans
and prospects for the Company constitute forward-looking statements
within the meaning of The Private Securities Litigation Reform Act of
1995. Actual results may differ materially from those indicated by such
forward-looking statements. The Company anticipates that subsequent
events and developments will cause the Company's views to change.
However, while the Company may elect to update these forward-looking
statements at some point in the future, the Company specifically
disclaims any obligation to do so.
[ Back To TMCnet.com's Homepage ]